Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DALLAS, Jan. 6, 2011 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring XOMA Ltd. (Nasdaq:XOMA). The report includes financial, comparative and investment analyses, and...
-
The number of shares and votes in Active Biotech has changed as a result of the exercise of employee stock options. Today, the last trading day of the month, there are in total 65,999,920 shares and...
-
Company Announcement No. 10/2010 9 December 2010 Zealand Pharma...
-
Selskabsmeddelelse Nr. 10/2010 9. december 2010 Zealand Pharma...
-
Laquinimod study met primary endpoint of reducing annualized relapse rate Treatment with laquinimod significantly slowed progression of disability Laquinimod data showed a favorable safety...
-
Lund, Sweden, November 18, 2010 - Active Biotech AB (NASDAQ OMX Nordic: ACTI) today announced that the COMP (Committee for Orphan Medicinal Products) adopted a positive opinion recommending the...
-
BERKELEY, Calif., Nov. 15, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that Timothy P. Walbert has been elected to...
-
BERKELEY, Calif., Nov. 11, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, today announced that Steven B. Engle, XOMA Chairman and...
-
BERKELEY, Calif., Nov. 10, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced additional positive results from an...
-
BERKELEY, Calif., Nov. 9, 2010 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office...